bpc-157 not approved fda statement Is Legal in 2026? Compounding Status Explained FDA to weigh easing limits
FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA's Overreach on Compounded Peptides FDA advisers weigh relaxing rules on three more peptides to widen access Reuters
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

